查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827818

2025年全球医疗仿生植入/人工器官市场报告

Medical Bionic Implant/Artificial Organs Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医疗仿生植入/人工器官市场规模强劲成长，从2024年的237.1亿美元成长至2025年的252.2亿美元，复合年增长率为6.3%。这段历史时期的成长可归因于老年人口的增长、材料科学的进步、政府的支持和资助、植入式设备的接受度不断提高以及患者意识的提升和相关教育的加强。

预计未来几年，医疗仿生植入/人工器官市场将强劲成长，到2029年将达到343.8亿美元，复合年增长率为8.1%。预测期内的成长可归因于生物列印和组织工程、生物混合植入的兴起、对心臟仿生学的关注、增强型感觉回馈以及仿生学中的再生医学。预测期内的主要趋势包括矫正器具和矫正器具的进步、对脑机介面 (BMIS) 的日益关注、用于移植的仿生器官、仿生植入的3D列印、人工智慧 (AI) 的整合、无线连接和远端监控。

医疗仿生植入物/植入器官包括用于复製受损或缺失的器官或身体部位功能的设备和机器。这些技术创新旨在帮助残疾人恢復身体功能，包括增强心臟和神经功能的植入等。

在医疗仿生植入和人工器官领域，主要分为两类：仿生植入和人工器官。仿生植入由电子或机电元件组成，旨在增强或恢復残障人士的身体功能。这些植入采用电子和/或机械技术，固定方式多种多样，包括植入式和外戴式。这些植入广泛应用于医院、诊所、研究机构和学术机构等各种场所。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供医疗仿生植入/人工器官市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的医疗仿生植入物/人工器官植入/人工器官细分市场、市场趋势和商机，以及您在仿生生物/植入/器官的行业取得成功所需的人工器官。本医疗仿生植入/人工器官市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年8.1%的预测成长率，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这种影响将透过对瑞士生物材料和微处理器的限制直接波及美国，这可能会减缓创新并增加用于改善生活矫正器具的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

预计交通事故和伤害的增加将在未来几年推动医疗仿生植入和人造器官市场的成长。交通事故是指在公共道路上发生的导致受害者受伤的事故。人造器官和组织替换主要用于修復因车祸、暴力犯罪、工业事故和难产等创伤性事件造成的器官损伤。例如，2022 年 5 月，美国负责交通安全的联邦机构国家公路交通安全管理局 (NHTSA) 报告机动车事故死亡人数增加了 10.5%，估计约有 42,915 人死亡，而前两年为 38,824 人。因此，交通事故和伤害的增加正在推动医疗仿生植入和人造器官市场的扩张。

慢性病的增加推动了医疗仿生植入和人工器官产业的成长。病程超过三个月的慢性病越来越普遍，这使得使用医疗仿生植入和人工器官来治疗糖尿病等疾病成为必要。例如，美国国家医学图书馆预测，到2050年，美国50岁以上至少患有一种慢性病的人数将增加99.5%。此外，正如世界卫生组织（WHO）在2022年9月所强调的那样，全球每年约有4,100万人死于非传染性疾病和慢性疾病，凸显了慢性病的流行是市场成长的驱动力。

在医疗仿生植入物和人工器官市场，策略联盟正变得越来越普遍。许多公司正在透过建立伙伴关係来巩固其市场地位。例如，2024年9月，美国医疗设备製造商Beta Bionics与美国医疗设备公司雅培实验室（Abbott Laboratories）合作，将其iLet Bionic Pancreas与FreeStyle Libre 3动态血糖监测系统整合。此次合作旨在透过与雅培先进的CGM技术无缝集成，增强iLet Bionic Pancreas用户的糖尿病管理。此外，2022年2月，专注于人工器官研究的美国研究服务公司HUMOTECH与美国义足大学密西根大学（University of Michigan）合作。此次合作旨在加速仿生腿控制软体的开发，该软体可为义肢使用者提供类似人类的腿部力量和自然的步态。作为此次合作的一部分，HUMOTECH正在开发其开放原始码义肢的升级版本，以便更好地服务义足用户和研究人员。

医疗仿生植入和人工器官市场涵盖心律调节器、辅助人工心臟、义肢和手指、外骨骼以及心臟瓣膜的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球医疗仿生植入/人工器官：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球医疗仿生植入/人造器官市场：成长率分析
  • 全球医疗仿生植入/人工器官市场表现：规模与成长，2019-2024
  • 全球医疗仿生植入/人工器官市场预测：规模与成长，2024-2029年，2034年
  • 全球医疗仿生植入/人工器官：总目标市场（TAM）

第六章 市场细分

  • 全球医疗仿生植入/人工器官市场类型、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 仿生植入
  • 人造器官
  • 全球医疗仿生植入/人工器官市场（依固定方法、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 嵌入式
  • 外用
  • 全球医疗仿生植入/人工器官市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 电子的
  • 机器
  • 全球医疗仿生植入/人工器官市场：应用、绩效及预测，2019-2024年、2024-2029年、2034年
  • 医院
  • 诊所
  • 研究和学术机构
  • 其他用途
  • 全球医疗仿生植入/人工器官市场：按仿生植入类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 仿生肢体
  • 仿生眼
  • 人工电子耳
  • 人造器官
  • 全球医疗仿生植入/人造器官市场：按人造器官类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟
  • 人工肾
  • 人工肝
  • 人工胰臟

第七章 区域和国家分析

  • 全球医疗仿生植入/人工器官市场：区域分析、预测与趋势，2019-2024 年、2024-2029 年、2034 年
  • 全球医疗仿生植入/人工器官市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 医疗仿生植入/人工器官市场：竞争格局
  • 医疗仿生植入/人工器官市场：公司简介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Services Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Ekso Bionics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Cochlear Limited
  • Cyberonics Inc.
  • LivaNova PLC
  • NeuroPace Inc.
  • Ossur India Private Limited
  • Vivani Medical Inc.
  • St Jude Medical India Private Limited
  • LifeNet Health Inc.
  • Ottobock SE & Co. KGaA
  • Edwards Lifesciences India Pvt. Ltd.
  • SynCardia Systems LLC
  • Demant A/S
  • Berlin Heart GmbH
  • Conmed Devices Private Limited
  • Wright Medical Group NV

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年医疗仿生植入/人工器官市场：提供新机会的国家
  • 2029年医疗仿生植入/人工器官市场：细分领域带来新机会
  • 2029年医疗仿生植入/人工器官市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22767u

Medical bionic implant artificial organs encompass devices or machinery utilized to replicate the functions of a damaged or missing body organ or part. These innovations serve to restore physical capabilities to individuals facing disabilities, spanning a range of implants that notably enhance cardiac and neurological functions.

The realm of medical bionic implants and artificial organs, two primary categories exist such as bionic implants and artificial organs. Bionic implants consist of electronic or mechatronic elements designed to augment or reinstate the physical abilities of individuals with disabilities. These implants vary in fixation methods, including implantable and externally worn options, leveraging electronic and mechanical technologies. They find applications across diverse settings such as hospitals, clinics, research institutes, academic institutions, and beyond.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The medical bionic implant/artificial organs market research report is one of a series of new reports from The Business Research Company that provides medical bionic implant/artificial organs market statistics, including medical bionic implant/artificial organs industry global market size, regional shares, competitors with a medical bionic implant/artificial organs market share, detailed medical bionic implant/artificial organs market segments, market trends and opportunities, and any further data you may need to thrive in the medical bionic implant/artificial organs industry. This medical bionic implant/artificial organs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical bionic implant/artificial organs market size has grown strongly in recent years. It will grow from $23.71 billion in 2024 to $25.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing geriatric population, advances in materials science, government support and funding, growing acceptance of implantable devices, patient awareness and education.

The medical bionic implant/artificial organs market size is expected to see strong growth in the next few years. It will grow to $34.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to bioprinting and tissue engineering, emergence of biohybrid implants, focus on cardiac bionics, enhanced sensory feedback, regenerative medicine in bionics. Major trends in the forecast period include advancements in prosthetics and orthotics, increasing focus on brain-machine interfaces (BMIS), bionic organs for transplantation, 3D printing in bionic implants, integration of artificial intelligence (AI), wireless connectivity and remote monitoring.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restrictions on biocompatible materials and microprocessors from Switzerland, slowing innovation and increasing costs for life-enhancing prosthetics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in road accidents and injuries is anticipated to drive the growth of the medical bionic implant and artificial organs market in the coming years. Road accidents refer to incidents on public roads that result in injuries to victims. Artificial organ and tissue replacements are performed to address organ damage primarily caused by traumatic events such as vehicle accidents, violent crimes, work-related injuries, or difficult births. For example, in May 2022, the National Highway Traffic Safety Administration (NHTSA), a US federal government agency focused on transportation safety, reported a 10.5% rise in motor vehicle crash fatalities, estimating approximately 42,915 deaths compared to 38,824 over the previous two years. Consequently, the increase in road accidents and injuries is driving the expansion of the medical bionic implant and artificial organs market.

The increasing prevalence of chronic diseases is poised to propel growth within the medical bionic implant and artificial organs sector. Chronic diseases persisting for three months or more are becoming more widespread, necessitating the use of medical bionic implants and artificial organs to manage conditions like diabetes. For example, projections from the National Library of Medicine indicate a 99.5% increase in individuals aged 50 and above with at least one chronic condition in the US by 2050. Moreover, as highlighted in September 2022 by the World Health Organization, approximately 41 million deaths each year globally are attributed to noncommunicable diseases or chronic ailments, emphasizing the market growth driven by the mounting prevalence of chronic diseases.

Strategic partnerships are becoming a prominent trend in the medical bionic implant and artificial organs market. Many companies in this sector are forming partnerships to strengthen their market positions. For example, in September 2024, Beta Bionics, a US-based medical equipment manufacturing company, collaborated with Abbott Laboratories, a US-based medical device firm, to integrate the iLet Bionic Pancreas with the FreeStyle Libre 3 continuous glucose monitoring (CGM) system. This collaboration aims to enhance diabetes management for users of the iLet Bionic Pancreas by providing seamless integration with Abbott's advanced CGM technology. Additionally, in February 2022, HUMOTECH, a US-based research services company focused on artificial organs, partnered with the University of Michigan, a public research university in the US. This partnership seeks to accelerate the development of bionic leg control software, which could provide prosthetic users with the strength and natural gait of a human leg. As part of this collaboration, HUMOTECH is developing updated versions of the open-source leg to better serve prosthesis users and researchers.

Major players in the medical bionic implant and artificial organs market are leveraging CAD and 3D printing technologies to gain a competitive edge. Utilizing Computer-Aided Design (CAD) and 3D printing technologies allows for precise customization and rapid prototyping of medical bionic implants, particularly in crafting artificial organs. For instance, CureTech's launch of the Polyether ether ketone (PEEK) cranial implant in April 2022 demonstrates the application of CAD software and 3D printing to create a biocompatible implant used in orthopedic applications like spinal fusion, joint replacement, and trauma surgery.

In May 2022, LivaNova PLC, a UK-centered medical device manufacturer, completed the acquisition of ALung Technologies, Inc., for an undisclosed sum. Foreseen to maintain a neutral impact on adjusted diluted earnings per share in 2022, this move signifies LivaNova's commitment to strategic portfolio investments. It includes the phased release of the next-generation heart-lung machine, Essenz, and the broadened applications in advanced circulatory procedures. ALung Technologies Inc., situated in the United States, specializes in the production of artificial organs.

Major companies operating in the medical bionic implant/artificial organs market are Medtronic PLC, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LivaNova PLC, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India Pvt. Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, Wright Medical Group N.V., Abiomed Inc., Baxter Laboratories Inc., Asahi Kasei Medical Co. Ltd., Getinge AB, Bornlife Prosthetic and Orthotic Inc., Sonova Holding AG, Biocontrol Medical Ltd., Orthofix International Inc., Aleva Neurotherapeutics SA, Second Sight Medical Products Inc., Touch Bionics Inc., Thoratec Corporation, CardiacAssist Inc., HeartWare International Inc., Synapse Biomedical Inc., Neurotech NA Inc., Retina Implant AG, Advanced Bionics AG, Med-El Elektromedizinische Gerate GmbH

Asia-Pacific was the largest region in the medical bionic implant/artificial organs market share in 2024. The regions covered in the medical bionic implant/artificial organs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical bionic implant/artificial organs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical bionic implant artificial organs market consists of sales of pacemakers, ventricular assist device, artificial limb and fingers, exoskeletons, heart valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Bionic Implant/Artificial Organs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical bionic implant/artificial organs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical bionic implant/artificial organs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical bionic implant/artificial organs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Bionic Implants; Artificial Organs
  • 2) By Method Of Fixation: Implantable; Externally Worn
  • 3) By Technology: Electronic; Mechanical
  • 4) By Application: Hospitals; Clinics; Research And Academic Institutes; Other Applications
  • Subsegments:
  • 1) By Bionic Implants: Bionic Limbs; Bionic Eyes; Cochlear Implants; Artificial Organs
  • 2) By Artificial Organs: Artificial Hearts; Artificial Kidneys; Artificial Livers; Artificial Pancreas
  • Companies Mentioned: Medtronic PLC; Boston Scientific Services Private Limited.; Abbott Laboratories Inc.; Zimmer Biomet Holdings Inc.; Ekso Bionics Holdings Inc.; Cochlear Limited; Cyberonics Inc.; LivaNova PLC; NeuroPace Inc.; Ossur India Private Limited; Vivani Medical Inc.; St Jude Medical India Private Limited; LifeNet Health Inc.; Ottobock SE & Co. KGaA; Edwards Lifesciences India Pvt. Ltd.; SynCardia Systems LLC; Demant A/S; Berlin Heart GmbH; Conmed Devices Private Limited; Wright Medical Group N.V.; Abiomed Inc.; Baxter Laboratories Inc.; Asahi Kasei Medical Co. Ltd.; Getinge AB; Bornlife Prosthetic and Orthotic Inc.; Sonova Holding AG; Biocontrol Medical Ltd.; Orthofix International Inc.; Aleva Neurotherapeutics SA; Second Sight Medical Products Inc.; Touch Bionics Inc.; Thoratec Corporation; CardiacAssist Inc.; HeartWare International Inc.; Synapse Biomedical Inc.; Neurotech NA Inc.; Retina Implant AG; Advanced Bionics AG; Med-El Elektromedizinische Gerate GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Bionic Implant/Artificial Organs Market Characteristics

3. Medical Bionic Implant/Artificial Organs Market Trends And Strategies

4. Medical Bionic Implant/Artificial Organs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Medical Bionic Implant/Artificial Organs Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Medical Bionic Implant/Artificial Organs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Medical Bionic Implant/Artificial Organs Market Growth Rate Analysis
  • 5.4. Global Medical Bionic Implant/Artificial Organs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Medical Bionic Implant/Artificial Organs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Medical Bionic Implant/Artificial Organs Total Addressable Market (TAM)

6. Medical Bionic Implant/Artificial Organs Market Segmentation

  • 6.1. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Implants
  • Artificial Organs
  • 6.2. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable
  • Externally Worn
  • 6.3. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic
  • Mechanical
  • 6.4. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Research And Academic Institutes
  • Other Applications
  • 6.5. Global Medical Bionic Implant/Artificial Organs Market, Sub-Segmentation Of Bionic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Limbs
  • Bionic Eyes
  • Cochlear Implants
  • Artificial Organs
  • 6.6. Global Medical Bionic Implant/Artificial Organs Market, Sub-Segmentation Of Artificial Organs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Hearts
  • Artificial Kidneys
  • Artificial Livers
  • Artificial Pancreas

7. Medical Bionic Implant/Artificial Organs Market Regional And Country Analysis

  • 7.1. Global Medical Bionic Implant/Artificial Organs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Medical Bionic Implant/Artificial Organs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Bionic Implant/Artificial Organs Market

  • 8.1. Asia-Pacific Medical Bionic Implant/Artificial Organs Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Bionic Implant/Artificial Organs Market

  • 9.1. China Medical Bionic Implant/Artificial Organs Market Overview
  • 9.2. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Bionic Implant/Artificial Organs Market

  • 10.1. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Bionic Implant/Artificial Organs Market

  • 11.1. Japan Medical Bionic Implant/Artificial Organs Market Overview
  • 11.2. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Bionic Implant/Artificial Organs Market

  • 12.1. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Bionic Implant/Artificial Organs Market

  • 13.1. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Bionic Implant/Artificial Organs Market

  • 14.1. South Korea Medical Bionic Implant/Artificial Organs Market Overview
  • 14.2. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Bionic Implant/Artificial Organs Market

  • 15.1. Western Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 15.2. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Bionic Implant/Artificial Organs Market

  • 16.1. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Bionic Implant/Artificial Organs Market

  • 17.1. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Bionic Implant/Artificial Organs Market

  • 18.1. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Bionic Implant/Artificial Organs Market

  • 19.1. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Bionic Implant/Artificial Organs Market

  • 20.1. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Bionic Implant/Artificial Organs Market

  • 21.1. Eastern Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 21.2. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Bionic Implant/Artificial Organs Market

  • 22.1. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Bionic Implant/Artificial Organs Market

  • 23.1. North America Medical Bionic Implant/Artificial Organs Market Overview
  • 23.2. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Bionic Implant/Artificial Organs Market

  • 24.1. USA Medical Bionic Implant/Artificial Organs Market Overview
  • 24.2. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Bionic Implant/Artificial Organs Market

  • 25.1. Canada Medical Bionic Implant/Artificial Organs Market Overview
  • 25.2. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Bionic Implant/Artificial Organs Market

  • 26.1. South America Medical Bionic Implant/Artificial Organs Market Overview
  • 26.2. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Bionic Implant/Artificial Organs Market

  • 27.1. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Bionic Implant/Artificial Organs Market

  • 28.1. Middle East Medical Bionic Implant/Artificial Organs Market Overview
  • 28.2. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Bionic Implant/Artificial Organs Market

  • 29.1. Africa Medical Bionic Implant/Artificial Organs Market Overview
  • 29.2. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Bionic Implant/Artificial Organs Market Competitive Landscape And Company Profiles

  • 30.1. Medical Bionic Implant/Artificial Organs Market Competitive Landscape
  • 30.2. Medical Bionic Implant/Artificial Organs Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Services Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ekso Bionics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Bionic Implant/Artificial Organs Market Other Major And Innovative Companies

  • 31.1. Cochlear Limited
  • 31.2. Cyberonics Inc.
  • 31.3. LivaNova PLC
  • 31.4. NeuroPace Inc.
  • 31.5. Ossur India Private Limited
  • 31.6. Vivani Medical Inc.
  • 31.7. St Jude Medical India Private Limited
  • 31.8. LifeNet Health Inc.
  • 31.9. Ottobock SE & Co. KGaA
  • 31.10. Edwards Lifesciences India Pvt. Ltd.
  • 31.11. SynCardia Systems LLC
  • 31.12. Demant A/S
  • 31.13. Berlin Heart GmbH
  • 31.14. Conmed Devices Private Limited
  • 31.15. Wright Medical Group N.V.

32. Global Medical Bionic Implant/Artificial Organs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Bionic Implant/Artificial Organs Market

34. Recent Developments In The Medical Bionic Implant/Artificial Organs Market

35. Medical Bionic Implant/Artificial Organs Market High Potential Countries, Segments and Strategies

  • 35.1 Medical Bionic Implant/Artificial Organs Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Medical Bionic Implant/Artificial Organs Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Medical Bionic Implant/Artificial Organs Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer